Australia
# |
Name |
Return on Equity (ROE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
44.10%
|
June 30, 2024 | USD 157.25 | 0.24% |
|
Australia |
|
2 |
17.55%
|
June 30, 2024 | USD 7.32 | 6.16% |
|
Australia |
|
3 |
15.24%
|
June 30, 2024 | USD 173.13 | 0.11% |
|
Australia |
|
4 |
13.48%
|
June 30, 2024 | USD 2.14 | 0.82% |
|
Australia |
|
5 |
11.06%
|
June 30, 2024 | USD 20.43 | 1.47% |
|
Australia |
|
6 |
7.29%
|
June 30, 2024 | USD 1.33 | 6.17% |
|
Australia |
|
7 |
4.04%
|
June 30, 2024 | USD 21.11 | 1.40% |
|
Australia |
|
8 |
3.50%
|
Dec. 31, 2023 | USD 15.47 | 4.25% |
|
Australia |
|
9 |
0.52%
|
Jan. 31, 2024 | USD 1.81 | -0.44% |
|
Australia |
|
10 |
-14.57%
|
Dec. 31, 2023 | USD 1.27 | -1.68% |
|
Australia |
|
11 |
-18.31%
|
June 30, 2024 | USD 1.58 | -2.06% |
|
Australia |
|
12 |
-22.54%
|
June 30, 2024 | USD 1.93 | -0.52% |
|
Australia |
|
13 |
-24.63%
|
June 30, 2024 | USD 0.62 | -2.68% |
|
Australia |
|
14 |
-38.36%
|
June 30, 2024 | USD 2.80 | 2.04% |
|
Australia |
|
15 |
-235.41%
|
Dec. 31, 2023 | USD 5.88 | 0.14% |
|
Australia |
The Pharmaceuticals company in Australia with the highest Return on Equity (ROE) is Pro Medicus Limited (ASX: PME.AX) at 44.10%.
The Pharmaceuticals company in Australia with the lowest Return on Equity (ROE) is Anteris Technologies Ltd (ASX: AVR.AX) at -235.41%.
The top 10 Pharmaceuticals companies in Australia by Return on Equity (ROE) are Pro Medicus Limited, Clinuvel Pharmaceuticals Limited, CSL Limited, Australian Clinical Labs Limited, EBOS Group Limited, PolyNovo Limited, Ansell Limited, Telix Pharmaceuticals Limited, Sigma Healthcare Limited and Cyclopharm Limited.
The bottom 10 Pharmaceuticals companies in Australia by Return on Equity (ROE) are Anteris Technologies Ltd, Mayne Pharma Group Limited, Trajan Group Holdings Limited, Immutep Limited, Mesoblast Limited, Cyclopharm Limited, Sigma Healthcare Limited, Telix Pharmaceuticals Limited, Ansell Limited and PolyNovo Limited.